|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
February 14, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
|
Top News
More News
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
February 13, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data
February 12, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
How The Parts Add Up: IBB Headed For $148
February 11, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
February 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight
February 09, 2020
Biotech stocks recovered last week along with the broader markets, which bounced back from a China coronavirus-induced sell-off. Big ... Read More
from Benzinga
Biotech Stock Segment Going Bananas In February 2020
February 09, 2020
One sector that is going crazy is the biotech stock sector. One thing we do know about markets that go bananas: if it’s unclear what their intention is you better stay at the sidelines. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
February 07, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Seriously, A Second Inverted Hammer Doji In Volatility
February 06, 2020
It either means that buying is just about over and hello correction or we have yet to see parabolic type buying come in. Regardless, something big is coming. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs
February 06, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
Volatility’s Inverted Hammer Doji Warning To Bulls
February 05, 2020
If IYT and XRT are signaling any impending weakness from here, watch the volatility index VXX to take out 14.75-14.86. Read More
from Blogs - TalkMarkets
Non-alcoholic steatohepatitis, or NASH, is a metabolic disorder caused by a buildup of fat in the liver, leading to liver inflammation ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.